Response to ‘Dupilumab: No elevated maternal risks in propensity‐matched cohort’ by Preuß et al.

Documenti analoghi

• Dupilumab shows no elevated risk for maternal adverse pregnancy outcomes: A propensity‐matched cohort study
  di: Sophie L. Preuß, et al.
  Pubblicazione: (2025)
• Increased rates of complications in diabetic patients undergoing Mohs micrographic surgery: An international, propensity‐matched, retrospective cohort study
  di: Hamza Malick, et al.
  Pubblicazione: (2024)
• Quantifying time to medical and/or surgical therapy after diagnosis of hidradenitis suppurativa and pilonidal sinus disease: A propensity‐matched real‐world cohort analysis
  di: Tara Sholji, et al.
  Pubblicazione: (2024)
• Increased risk of cutaneous squamous cell carcinoma in hidradenitis suppurativa: A matched cohort study
  di: Matthew H. Lanehart, et al.
  Pubblicazione: (2025)
• Haematopoietic stem cell transplant in cutaneous T‐cell lymphomas: A multicentre propensity‐score matched study
  di: Lía Bejarano, et al.
  Pubblicazione: (2025)